
Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More

The US Food and Drug Administration sent a letter to trade associations of manufacturers, wholesalers, and pharmacies to recommend procedures for preventing and responding to the theft of regulated products.

FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.

FDA wants industry to talk to them about the science underlying process innovations-really.

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?

A Pharma Business Imperative.

When vessels, seals, and cooling units go haywire, operators must get in the mix.

New Draft Guidance for Solid Oral Dosage Forms Focuses on Physical Chemical Identifiers. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010."

Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

INTERPHEX 2010 will take place this week at the Jacob K. Javits Center in New York.

FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

Cephalon Completes Acquisition of Mepha; Xcellerex Appoints President and CEO; and More.

Eli Lily Wins Court Battle; Genzyme Appoints COO; And More.

As the industry continues to evolve, do we know where we're headed?

Laboratory personnel share interesting tales as well as stories of unexpected tails.

As demand for global vaccine development and production grows, all eyes are turning to Asia.

The BIO convention, and healthcare reform, could re-energize biotech.

Aseptic blow–fill–seal minimizes human intervention in the packaging process.

In an attempt to strengthen safeguards against counterfeit, diverted, subpotent, misbranded, adulterated, or expired drugs, FDA issued a new final guidance for industry.

Pfizer Invests In Nodality; SOCMA Approves New Members; And More.

FDA issued a new guidance for industry to help new drug applicants write the dosage and administration section of their products' labels.

Merck Ends Partnership With Dynavax; PhRMA Elects Officers; And More.

Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.